Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Reuter

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|September 6, 2017
Prevention of hearing loss in patients with multidrug-resistant tuberculosisHelen Cox, Anja Reuter, Jennifer Furin, et al.
Paediatric Respiratory Reviews|April 8, 2020
Preventing tuberculosis in children: A global health emergencyAnja Reuter, James A Seddon, Ben J Marais, et al.
The Lancet. Global Health|September 16, 2022
Household contact management for rifampicin-resistant tuberculosisAnja Reuter, Ivy Apolisi, Johnny Daniels, et al.
The Lancet. Infectious Diseases|March 27, 2019
The STREAM trial: missed opportunities and lessons for future clinical trialsMarian Loveday, Anja Reuter, Jennifer Furin, et al.
The Pediatric Infectious Disease Journal|April 13, 2021
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five PatientsRebecca Acquah, Erika Mohr-Holland, Johnny Daniels, et al.
The Lancet. Infectious Diseases|August 23, 2024
Waiting is no longer an option for household contacts of people with drug-resistant tuberculosisJean Pannikottu, Anja Reuter, Elize Pietersen, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
Provision of Decentralized TB Care Services: A Detect-Treat-Prevent Strategy for Children and Adolescents Affected by TBStella Zawedde-Muyanja, Anja Reuter, Marco A Tovar, et al.
The Lancet. Infectious Diseases|February 19, 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPauline Howell, Jonathan Stillo, Anja Reuter, et al.
The Lancet. Child & Adolescent Health|February 20, 2021
Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemicErika Mohr-Holland, Bianca Douglas-Jones, Ivy Apolisi, et al.
Eclinicalmedicine|March 11, 2020
Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South AfricaErika Mohr-Holland, Anja Reuter, Jennifer Furin, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|September 6, 2017
Prevention of hearing loss in patients with multidrug-resistant tuberculosisHelen Cox, Anja Reuter, Jennifer Furin, et al.
Paediatric Respiratory Reviews|April 8, 2020
Preventing tuberculosis in children: A global health emergencyAnja Reuter, James A Seddon, Ben J Marais, et al.
The Lancet. Global Health|September 16, 2022
Household contact management for rifampicin-resistant tuberculosisAnja Reuter, Ivy Apolisi, Johnny Daniels, et al.
The Lancet. Infectious Diseases|March 27, 2019
The STREAM trial: missed opportunities and lessons for future clinical trialsMarian Loveday, Anja Reuter, Jennifer Furin, et al.
The Pediatric Infectious Disease Journal|April 13, 2021
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five PatientsRebecca Acquah, Erika Mohr-Holland, Johnny Daniels, et al.
The Lancet. Infectious Diseases|August 23, 2024
Waiting is no longer an option for household contacts of people with drug-resistant tuberculosisJean Pannikottu, Anja Reuter, Elize Pietersen, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
Provision of Decentralized TB Care Services: A Detect-Treat-Prevent Strategy for Children and Adolescents Affected by TBStella Zawedde-Muyanja, Anja Reuter, Marco A Tovar, et al.
The Lancet. Infectious Diseases|February 19, 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPauline Howell, Jonathan Stillo, Anja Reuter, et al.
The Lancet. Child & Adolescent Health|February 20, 2021
Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemicErika Mohr-Holland, Bianca Douglas-Jones, Ivy Apolisi, et al.
Eclinicalmedicine|March 11, 2020
Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South AfricaErika Mohr-Holland, Anja Reuter, Jennifer Furin, et al.
Pageof 4